The Non-LCH Steering Committee is responsible for charting strategic direction of the HS in their specified areas, including conduct of clinical trials and engagement with the broader group of investigators interested in rare histiocytoses. 

Current members of the Non-LCH Steering Committee Include:

Gaurav Goyal - Chair
University of Alabama at Birmingham - Birmingham, AL USA
Term of Office: 2024 - 2028 

Eli Diamond
Memorial Sloan Kettering Cancer Center - New York, NY, USA
Term of Office: 2023 - 2027

Benjamin Durham
Memorial Sloan Kettering Cancer Center - New York, NY USA
Term of Office: 2021 - 2025

Jean-Francoise Emile
Versailles University, Paris-Saclay University - Boulogne, France
Term of Office: 2021 - 2025 

Ronald Go
Mayo Clinic - Rochester, MN USA
Term of Office: 2025 - 2029